Drug Trial Radar · NCT05690646
Prophylactic Effect of Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid on Reducing Complications After Cardiac Surgery
Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
491
Actual
Start
Jan 28, 2023
Primary completion
Mar 24, 2023
Study completion Aug 1, 2024
Sponsor
- Lead sponsor
- China National Center for Cardiovascular DiseasesGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Jan 19, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prophylactic effect of nirmatrelvir/ritonavir and ursodeoxycholic acid on reducing complications after cardiac surgery during covid-19 pandemics (the pep trial) is a multicenter, randomized controlled trial. The aim of the pep trial is to investigate whether prophylactic use of nirmatrelvir/ritonavir and ursodeoxycholic could reduce complications after cardiac surgery.
Conditions
- Cardiac Surgery
Interventions
Nirmatrelvir/ritonavirDrug
nirmatrelvir 300mg q12h and ritonavir 100 mg q12h for 5 days
Ursodeoxycholic acidDrug
ursodeoxycholic acid 15mg/kg/day bid for5 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- MACCETime frame: 30 days after surgery or during hospitalization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Fuwai Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.